Gregory A. Bonfiglio
Mr. Bonfiglio is the Founder & Managing Partner of Proteus. He was an early investor in the field of stems cell & regenerative medicine, and continues to be actively involved in the field. He is a frequent speaker at Regenerative Medicine Conferences. Mr. Bonfiglio is a Member of the ISSCR and is on their Advisory Board, as well as their Finance Committee. He also is a Member of the ISCT and is on their Commercialization Committee.
Mr. Bonfiglio is on the Boards of StemCyte, Inc. (cord blood storage & therapeutics); and California Stem Cell, Inc. (reagents & CNS therapeutics from hESCs). He is the Chairman of the Board of the Centre for Commercialization of Regenerative Medicine (CCRM; RM Translation Center in Toronto, Canada), and Co-Founder and Chairman of the Regenerative Medicine Coalition.
Mr. Bonfiglio has over 25 years experience working with technology companies. From 2000–2005, he was a General Partner with Anthem Venture Partners – an early stage venture fund in California. Whilst at Anthem, Mr. Bonfiglio led investments in both biotechnology and IT. Anthem generated top quartile returns for its investors.
Prior to joining Anthem, he was a Partner with Morrison & Foerster, where he worked extensively with technology clients. Mr. Bonfiglio was an Adjunct Professor of Law at Stanford Law School, from 1996 to 2000. In 2007, he was a Guest Lecturer at the Stanford Business School on the Commercialization of RM Technologies. From 1995-2005, he was a regular Guest Lecturer at the UC Berkley Haas Business School.
Mr. Bonfiglio received his B.A. in Mathematics (magna cum laude) from Michigan State University in 1975, and his J.D. (magna cum laude) from the University of Michigan Law School in 1981. He lives in Portola Valley, California, and is actively involved in the community.